Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California. Show more

Location: 919 East Hillsdale Boulevard, Suite 250, Foster City, CA, 94404, United States | Website: https://www.geron.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

893.2M

52 Wk Range

$1.09 - $4.83

Previous Close

$1.40

Open

$1.40

Volume

4,167,236

Day Range

$1.36 - $1.42

Enterprise Value

630.3M

Cash

388M

Avg Qtr Burn

-44.57M

Insider Ownership

0.09%

Institutional Own.

81.97%

Qtr Updated

06/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.